Answers are grounded in this paper and cite their sources.
Pilot feasibility study compares OxyJet's effects with standard CPAP therapy in hypoxemic adults, suggesting it as a viable alternative.
OxyJet's performance was first assessed through benchtop testing following the UK-MHRA RMCPAP protocol. This was followed by preliminary human testing in healthy volunteers and hypoxemic patients to evaluate safety and usability. A pilot feasibility study involving hypoxemic adult patients in Dhaka, Bangladesh, was then conducted to compare the device's physiological effects with those of standard CPAP therapy.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: